Several pathways, including the CEACAM6-SMAD2/3 pathway [79], NF-kappa beta pathway [86], and AKT pathway [86,89], were associated with TRIM proteins that promoted cancer progression of bladder cancer. This evidence concerns the gene AKT1 and urinary bladder cancer.